The aging of America is taking a toll on the health care system. By 2050, the cost of treating Alzheimer's patients will hit $1 trillion a year.
Despite piles of research on the skin cancer risks of sun exposure and tanning beds, dermatologists and cancer groups struggle to persuade people to protect their skin from ultraviolet rays.
The average US refrigerator is 15 percent larger than 30 years ago, and one out of four homes has a second one. See a problem?
Local foods sales are booming, having doubled to $11 billion in the past ten years. Wal-Mart, Safeway and other big firms are trying to cash in.
With 12 million Americans allergic to one food item or another, sales of specialty foods are soaring.
According to Campus Grotto's just-released report on the 2012-2013 year, the top 10 colleges all have an average total cost of more than $55,000 per year.
Given the skyrocketing cost of post-secondary education; static, underwhelming graduation rates and a dismal job market, some say smart, talented and driven teens are better off diving into the real world without a bachelor's degree.
Marijuana in California is seemingly coming full circle. It gone from being a banned substance to legal under state law for medical uses to being banned again in many cities. Now it turns out that pot is also bad for the animals.
Scientists once revealed that sitting all day leads to a cascade of harmful metabolic effects. Now there's new evidence that not only is it making you fatter, but it might also be making you dumber.
The marketplace for narcotics isn’t what it used to be. Read ahead to see a list of dangerous drugs that are legal in many American states.
Find out which second-quarter top performer got the most votes.
As part of our annual study, America’s Top States for Business, we grade states on several criteria in this important category of Technology & Innovation.
CNBC.com presents a list of people who survived tragedies and responded by creating new careers and businesses. These new ventures helped them cope and inspired others.
So it was all about semantics, a “tax” vs a “penalty”, but the bottom line is the same, the law stands.
After the shock wears off, we’re all going to have to show up to work and get back to the business of doing our jobs. So what will that look like for those of us on the front lines of the economy?
The Supreme Court has rendered its opinion and now we’re going to have around 30 million more consumers entering a health care system that is already broken… and broke. What should be done? In a word: outcomes.
European regulators have rejected Celgene’s request for an expanded approval of its multiple myeloma drug Revlimid to treat newly diagnosed patients, a stunning setback that slams the brakes on the company's growth.
Congress doesn’t often get a second chance to do the right thing. But when it comes to health care, the U.S. Supreme Court may provide lawmakers a historic opportunity to do just that.
The makers of a deer antler velvet product are suing Major League Baseball for libel after the league told players to stop taking the performance enhancer so as not to risk testing positive for a steroid that wasn't listed as an ingredient.
Merck said Friday that its first-quarter profit jumped 67 percent despite lower-than-expected sales, due to lower spending on production, marketing and research as well as an arbitration charge a year ago.